ArticleScientific reports2025
Causal role of immune cells in varicose veins: insights from a Mendelian randomization study.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Causal Association Between Gut Microbiota, Plasma Metabolites, and Prostate Cancer: Two-Step Mendelian Randomization Study.Dose-response : a publication of International Hormesis SocietyArticle
- Novel susceptibility genes for varicose veins revealed by a cross-tissue transcriptome-wide association study.Science progressArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Immune factors play a pivotal role in the development of vascular diseases. However, research on the relationship between immune cells and the risk of varicose veins remains limited. In this study, we utilized summary statistics from a genome-wide association study (GWAS) and employed bidirectional two-sample Mendelian randomization (MR) analysis to investigate the causal relationship between immune cell phenotypes and varicose veins. Sensitivity analyses were conducted to ensure the robustness of the results, including Cochran's Q test, MR Egger intercept test, leave-one-out analysis, and MR pleiotropy residual sum and outlier (MR-PRESSO) test. Additionally, results were subjected to false discovery rate (FDR) correction. Finally, Bayesian Weighted Mendelian Randomization (BWMR) was utilized to further validate the findings of the MR analysis. Our study identified significant causal associations between 5 immune cell phenotypes and the risk of varicose veins (FDR < 0.05). Specifically, CD86 on myeloid dendritic Cell and CD33 on CD33 + HLA DR + CD14dim show a significant positive causal relationship with the risk of varicose veins, while BAFF-R on IgD- CD24- B cell, BAFF-R on IgD + CD24- B cell, and BAFF-R on IgD + CD38- B cell exhibit a significant negative causal relationship with the risk of varicose veins. Additionally, when FDR was adjusted to 0.2, we found additional 7 immune cell phenotypes that are potentially associated with the risk of varicose veins. In particular, CD33 on CD33 + HLA DR+, CD33 on CD33 + HLA DR + CD14-, CD4 + T cell %T cell and CD39 + CD8 + T cell %CD8 + T cell are positively associated with the risk of varicose veins. In contrast, BAFF-R on B cell, BAFF-R on memory B cell and PDL-1 on CD14- CD16 + monocyte are negatively associated with the risk of varicose veins. The sensitivity analyses yielded results consistent with the main findings. Upon testing with the BWMR method, all results were consistent with those from the MR analysis, except for CD39 + CD8 + T cell %CD8 + T cell. Our study confirms a potential causal relationship between immune cells and varicose veins. This study provides new avenues to explore the mechanisms of varicose veins and lays the foundation for future investigations into targeted prevention strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.